Security
SS Innovations International Inc. Common Stock · SSII
SSIINASDAQCommon stockCurrentCIK 1676163Updated Oct 14, 2026
Name history
SS Innovations International, Inc. · through Oct 13, 2026AVRA Medical Robotics, Inc. · through Apr 14, 2023
SSII price & chart
Loading TradingView…
NASDAQ:SSII on TradingView ↗About the company
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.
In the news
Recent filings
Other Events
Items 8.01, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
4 filing
424B5 filing
Regulation FD Disclosure
Items 7.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 69,577,027Source | 39,021,252Source | 96,982,013Source | 69,977,771Source | 35,667,103Source | 90,546,889Source | 63,456,961Source | 35,201,583Source | 74,226,217Source | 42,385,213Source | 31,515,994Source | 4,371,441Source |
| Property, Plant and Equipment, NetUSD | 8,249,725Source | 3,801,736Source | 8,637,145Source | 8,274,135Source | 2,774,967Source | 8,831,423Source | 7,044,307Source | 2,176,439Source | 9,100,546Source | 5,385,955Source | 706,405Source | 11,399Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 5,681,657Source | 220,357Source | 13,647,430Source | 11,375,265Source | 608,215Source | 15,979,714Source | 15,873,217Source | 948,119Source | 3,206,406Source | 466,500Source | 2,022,276Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 6,917,040Source | 3,912,702Source | 16,986,089Source | 5,973,923Source | 4,280,188Source | 14,054,376Source | 3,962,202Source | 4,964,543Source | 12,398,542Source | 4,466,047Source | 1,901,244Source | — |
| Inventory, NetUSD | 20,036,005Source | 9,423,580Source | 18,481,603Source | 18,260,141Source | 7,217,663Source | 17,066,091Source | 14,295,141Source | 6,921,892Source | 17,064,002Source | 10,206,898Source | 7,017,913Source | — |
| Assets, CurrentUSD | 48,424,838Source | 25,081,508Source | 71,453,952Source | 50,786,526Source | 23,269,096Source | 66,261,517Source | 47,619,943Source | 23,591,554Source | 48,800,659Source | 27,416,291Source | 21,428,659Source | 4,360,042Source |
| Prepaid Expense and Other Assets, CurrentUSD | 9,766,203Source | 4,736,516Source | 13,690,369Source | 9,292,684Source | 4,255,897Source | 11,530,000Source | 7,602,794Source | 3,625,957Source | 10,194,059Source | 6,438,338Source | 3,890,017Source | — |
| Operating Lease, Right-of-Use AssetUSD | 2,458,573Source | 2,803,090Source | 3,045,707Source | 2,654,775Source | 2,448,965Source | 2,499,490Source | 2,629,225Source | 2,552,193Source | 2,754,020Source | 2,623,880Source | 2,657,554Source | — |
| Other Assets, NoncurrentUSD | 126,121Source | 65,809Source | 170,974Source | 75,647Source | — | 138,099Source | 72,877Source | 70,373Source | 97,673Source | 143,885Source | 6,825Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 29,927,721Source | 25,331,432Source | 43,580,790Source | 27,954,902Source | 20,894,689Source | 36,023,476Source | 22,902,671Source | 18,452,813Source | 36,007,966Source | 28,928,110Source | 11,797,916Source | — |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 1Source | 1Source | 1Source | 1Source | 1Source | 1Source | 1Source | 1Source | 1Source | 1Source | 1Source | — |
| Common Stock, Value, IssuedUSD | 19,358Source | 17,087Source | 20,017Source | 19,358Source | 17,075Source | 20,013Source | 19,354Source | 17,075Source | 19,416Source | 17,157Source | 17,072Source | 5,389Source |
| Additional Paid in CapitalUSD | 93,353,412Source | 54,852,142Source | 118,509,309Source | 91,526,999Source | 52,628,232Source | 116,549,124Source | 89,705,829Source | 50,451,186Source | 95,111,511Source | 56,952,200Source | 43,457,937Source | 11,005,895Source |
| Retained Earnings (Accumulated Deficit)USD | -53,318,557Source | -41,739,156Source | -62,033,855Source | -49,600,593Source | -38,493,673Source | -59,372,505Source | -49,343,900Source | -34,353,103Source | -55,789,934Source | -43,662,547Source | -24,511,350Source | -10,691,071Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,304,825Source | -340,171Source | -3,994,166Source | -822,813Source | -279,138Source | -3,573,137Source | -726,911Source | -266,306Source | -2,022,660Source | -749,625Source | -195,499Source | — |
| Stockholders' Equity Attributable to ParentUSD | 39,649,306Source | 13,689,820Source | 53,401,223Source | 42,022,870Source | 14,772,413Source | 54,523,413Source | 40,554,290Source | 16,748,770Source | 38,218,251Source | 13,457,103Source | 19,718,078Source | 320,213Source |
| Liabilities and EquityUSD | 69,577,027Source | 39,021,252Source | 96,982,013Source | 69,977,771Source | 35,667,103Source | 90,546,889Source | 63,456,961Source | 35,201,583Source | 74,226,217Source | 42,385,213Source | 31,515,994Source | 4,371,441Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 21,187,549Source | 18,499,086Source | 31,891,727Source | 19,611,108Source | 14,977,953Source | 26,045,003Source | 14,996,713Source | 13,032,564Source | 26,241,698Source | 21,330,222Source | 8,473,720Source | 4,051,229Source |
| Operating Lease, Liability, CurrentUSD | 341,371Source | 449,301Source | 687,707Source | 354,626Source | 428,713Source | 576,237Source | 368,309Source | 415,331Source | 579,169Source | 409,518Source | 396,784Source | — |
| Accounts Payable, CurrentUSD | 4,656,966Source | 1,798,612Source | 5,265,754Source | 6,079,794Source | 1,126,373Source | 4,403,170Source | 3,641,410Source | 1,827,635Source | 5,127,193Source | 2,312,382Source | 901,552Source | — |
| Operating Lease, Liability, NoncurrentUSD | 2,273,111Source | 2,478,849Source | 2,549,823Source | 2,452,389Source | 2,125,946Source | 2,086,534Source | 2,402,653Source | 2,238,259Source | 2,337,697Source | 2,349,118Source | 2,351,113Source | — |
| Other Liabilities, NoncurrentUSD | 189,402Source | — | 443,515Source | 111,880Source | — | 390,656Source | 98,078Source | — | 288,764Source | 74,817Source | — | — |
| Additional Financial Items | ||||||||||||
| Accounts Receivable, after Allowance for Credit LossUSD | 13,839,740Source | 7,344,141Source | 25,497,143Source | 10,421,312Source | 7,326,971Source | 21,320,287Source | 6,780,245Source | 7,451,490Source | 20,965,196Source | 7,765,079Source | — | — |
| Accrued Liabilities, CurrentUSD | — | — | — | 3,783,693Source | — | — | — | — | — | — | 144,001Source | 5,700Source |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD | — | — | 20,870Source | 19,822Source | — | -4,781Source | — | — | 67,376Source | — | — | — |
| Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | 510,189Source | — |
| Long-term Debt, Current MaturitiesUSD | — | — | — | — | — | — | — | 521,873Source | — | — | 510,189Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -6,119,381Source | — | — | — | — | — | — | -21,128,390Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 2,095,163Source | 2,451,355Source | 2,178,156Source | 1,630,295Source | 3,144,315Source | 2,379,212Source | 8,128,103Source | 14,342,784Source | 9,723,492Source | 865,468Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 245,111Source | -1,275,750Source | 13,037,284Source | 4,890,032Source | 3,071,640Source | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -4,159Source | 5,082,673Source | 8,070,786Source | 7,691,518Source | 6,113,810Source | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -704,764Source | 1,329,028Source | 2,877,810Source | 1,410,830Source | — | — |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | -301,036Source | — | -512,865Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,311,936Source | -6,103,374Source | -18,542,987Source | -9,503,030Source | -15,370,894Source | -1,435,841Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -54,189Source | -872,804Source | -3,659,058Source | -661,479Source | -444,077Source | -3,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 54,189Source | 872,804Source | 3,659,058Source | 661,479Source | 2,763,385Source | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 18,159,697Source | 22,406,019Source | 26,166,556Source | 9,425,980Source | 22,796,286Source | 5,381,431Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | — | — | — | — | — | -945,590Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 12,039,247Source | 6,152,262Source | 22,671,023Source | 17,605,678Source | 24,005,680Source | 22,078,788Source | 9,603,020Source | 6,623,535Source | 7,087,845Source | 1,351,364Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -1,390,912Source | 25,412Source | -985,026Source | 274,219Source | -168,095Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | 3,144,315Source | 2,379,212Source | 8,128,103Source | 14,342,784Source | 9,723,492Source | — |
| DepreciationUSD | — | — | 297,173Source | 119,502Source | 346,364Source | 260,361Source | 323,747Source | 208,882Source | 1,075,907Source | — | 162,623Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | 46,005Source | 12,094Source | 113,842Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 1,239,179Source |
| Income Tax Expense (Benefit)USD | — | — | 1,847,059Source | — | 505,276Source | 353,729Source | 151,352Source | — | 3,966,440Source | — | — | — |
| InterestExpenseNonoperatingUSD | — | — | 176,636Source | 247,616Source | 344,761Source | 216,800Source | 284,051Source | 379,905Source | 1,108,637Source | 973,235Source | 894,621Source | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | 25,448Source | — | 14,697Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,717,964Source | -3,245,483Source | -2,661,350Source | -256,691Source | -3,582,571Source | -5,681,353Source | -12,127,387Source | -19,151,197Source | -20,878,292Source | -2,213,012Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -6,119,381Source | — | — | — | — | — | — | -20,941,972Source | — |
| Nonoperating Income (Expense)USD | — | — | -35,634Source | -40,715Source | 115,280Source | 24Source | 207,538Source | 240,500Source | 33,087Source | -175,235Source | -604,308Source | 234,594Source |
| Operating ExpensesUSD | — | — | 8,000,207Source | 5,522,175Source | 9,372,304Source | 5,818,044Source | 8,965,978Source | 7,009,061Source | 27,738,289Source | 27,428,328Source | 20,999,512Source | 2,447,606Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 220,493Source | 205,275Source | 827,521Source | 753,449Source | 35,902Source | — |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | 290,313Source | — |
| Payments for Repurchase of WarrantsUSD | — | — | — | — | — | — | — | — | — | — | 12,360Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | 412,056Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | 100,000Source | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | 13,939,709Source | 10,000,305Source | — | — | 42,484,747Source | — | 5,875,314,000Source | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | — | — | — | — | — | — | 42,484,747Source | 20,649,528Source | 5,875,314Source | — |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | — |
| Selling, General and Administrative ExpenseUSD | — | — | 4,821,552Source | 2,508,479Source | 4,452,090Source | 3,428,788Source | 4,502,476Source | 3,410,872Source | 14,848,439Source | 10,157,768Source | 10,064,622Source | — |
| Operating Income (Loss)USD | — | — | -1,835,271Source | -3,204,768Source | -2,271,354Source | 97,014Source | -3,638,757Source | -5,921,853Source | -8,194,034Source | -18,975,962Source | -20,273,984Source | — |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | 290,313Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -1,870,905Source | -3,245,483Source | -2,156,074Source | 97,038Source | -3,431,219Source | -5,681,353Source | -8,160,947Source | -19,151,197Source | -20,878,292Source | -2,213,012Source |
| Income Tax Expense (Benefit)USD | — | — | 1,847,059Source | — | 505,276Source | 353,729Source | 151,352Source | — | 3,966,440Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,717,964Source | -3,245,483Source | -2,661,350Source | -256,691Source | -3,582,571Source | -5,681,353Source | -12,127,387Source | -19,151,197Source | -20,878,292Source | -2,213,012Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.02Source | -0.02Source | -0.01Source | 0Source | -0.02Source | -0.03Source | -0.06Source | -0.11Source | -0.14Source | -0.05Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.02Source | -0.02Source | -0.01Source | 0Source | -0.02Source | -0.03Source | -0.06Source | -0.11Source | -0.14Source | -0.05Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 193,589,845Source | 170,781,337Source | 200,136,068Source | 193,571,635Source | 196,007,956Source | 178,836,342Source | 190,009,159Source | 170,847,444Source | 144,866,674Source | 40,878,824Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 202,856,501Source | 181,885,269Source | 209,422,550Source | 202,835,698Source | 205,309,556Source | 188,599,859Source | 198,699,461Source | 181,203,673Source | 152,069,825Source | 40,878,824Source |
| Interest Expense (non-operating)USD | — | — | 176,636Source | 247,616Source | 344,761Source | 216,800Source | 284,051Source | 379,905Source | 1,108,637Source | 973,235Source | 894,621Source | — |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 297,173Source | 119,502Source | 346,364Source | 260,361Source | 323,747Source | 208,882Source | 1,075,907Source | 436,005Source | 152,738Source | 9,143Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | 46,005Source | 12,094Source | 113,842Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 1,239,179Source |
| Gross ProfitUSD | — | — | 6,164,936Source | 2,317,407Source | 7,100,950Source | 5,915,058Source | 5,327,221Source | 1,087,208Source | 19,544,255Source | 8,452,366Source | 725,528Source | — |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | — | — | — | — | — | — | — | — | -20,878,292Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | -3,618,366Source | -14,730,544Source | -17,924,310Source | — | — |
| Interest and Other IncomeUSD | — | — | 141,002Source | 206,901Source | 460,041Source | 216,824Source | 491,589Source | 620,405Source | 1,141,724Source | 798,000Source | — | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 523,356Source | 45,529Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | 43,555Source | 155,015Source | 271,633Source | — | — | — |
| Interest Income (Expense), NetUSD | — | — | — | — | — | — | 261,878Source | 79,236Source | 497,549Source | 335,222Source | 151,497Source | — |
| Interest Income, OtherUSD | — | — | — | — | — | — | 415,465Source | 140,928Source | 625,883Source | 418,426Source | — | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | 25,448Source | — | 14,697Source | — | — | — |
| Investment Income, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 148Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -6,119,381Source | — | — | — | — | — | — | -20,941,972Source | — |
| Nonoperating Income (Expense)USD | — | — | -35,634Source | -40,715Source | 115,280Source | 24Source | 207,538Source | 240,500Source | 33,087Source | -175,235Source | -604,308Source | 234,594Source |
| Operating ExpensesUSD | — | — | 8,000,207Source | 5,522,175Source | 9,372,304Source | 5,818,044Source | 8,965,978Source | 7,009,061Source | 27,738,289Source | 27,428,328Source | 20,999,512Source | 2,447,606Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 220,493Source | 205,275Source | 827,521Source | 753,449Source | 35,902Source | — |
| Other Cost of Operating RevenueUSD | — | — | — | — | — | — | — | — | — | — | 487,538Source | — |
| Other ExpensesUSD | — | — | — | — | — | — | — | — | — | 834,291Source | 78,017Source | — |
| Research and Development ExpenseUSD | — | — | 786,319Source | 442,839Source | 2,395,694Source | 498,600Source | 995,440Source | 1,010,095Source | 3,685,840Source | 2,491,771Source | 1,058,660Source | 72,959Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | 13,939,709Source | 10,000,305Source | — | — | 42,484,747Source | — | 5,875,314,000Source | — |
| Total Revenue | — | — | —Source | —Source | — | —Source | —Source | —Source | — | — | — | — |
Offerings
Registration 333-295501
Filing attachments
ea030835701ex99-1.htm · 8-K · 2026-10-13
Exhibit 99.1 SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company’s 510(k) Submission for the SSi Mantra FORT LAUDERDALE, Fla. - October 13, 2026 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that, on October 5, 2026, the Company submitted its response …
Read attachment ↗ea030806201ex4-1.htm · 8-K · 2026-10-13
Exhibit 4.1 SECURED CONVERTIBLE PROMISSORY NOTE October 9, 2026 U.S. $21,025,000.00 FOR VALUE RECEIVED, SS Innovations International, Inc., a Florida corporation (“Borrower”), promises to pay to Growth Capital Partners, LLC, a Utah limited liability company, or its successors or assigns (“Lender”), $21,025,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is thirty-six (36) months after the Purchase Price Date (as defined below) (the “Maturity Dat…
Read attachment ↗ea030757901ex99-1.htm · 8-K · 2026-10-05
Exhibit 99.1 We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation October 2026 Nasdaq: SSII © 2026 SS INNOVATIONS INTERNATIONAL, INC. 2 No Offering of Securities No offer is made by this Company Presentation (this "Presentation") to invest in SS Innovations International, Inc. (the "Company") or to purchase any of its securities. Any offer to make such an investment or purchase and such investment or purchase will be ma…
Read attachment ↗ea030502401ex99-1.htm · 8-K · 2026-09-10
EX-99.1 2 ea030502401ex99-1.htm PRESS RELEASE, DATED SEPTEMBER 10, 2026 Exhibit 99.1 SS Innovations Provides Update on Continuing Progress and Milestones -- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla. - September 10, 2026 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicat…
Read attachment ↗ea030188701ex99-1.htm · 8-K · 2026-08-13
EX-99.1 2 ea030188701ex99-1.htm PRESS RELEASE, DATED AUGUST 13, 2026 Exhibit 99.1 SS Innovations Reports Second Quarter 2026 Financial Results Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales FORT LAUDERDALE, FLA - August 13, 2026 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global popula…
Read attachment ↗ea029838101ex99-1.htm · 8-K · 2026-07-17
EX-99.1 2 ea029838101ex99-1.htm PRESS RELEASE, DATED JULY 17, 2026 Exhibit 99.1 SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026 Company’s advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event FORT LAUDERDALE, Fla. - July 17, 2026 - via IBN - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a de…
Read attachment ↗